Vaccine development

Infectious Disease Clinics of North America

Volumn 10, Issue 3, 1996, Pages 469-488

  Takahashi, M ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE; VIRUS DNA;

ACUTE LEUKEMIA; CHICKENPOX; DNA CLEAVAGE; DRUG DEVELOPMENT; HUMAN; IMMUNOPATHOGENESIS; INFECTION CONTROL; MALIGNANT NEOPLASTIC DISEASE; PUBLIC HEALTH; REVIEW; VACCINATION; VARICELLA ZOSTER VIRUS; VIREMIA; VIRUS ISOLATION; ARTICLE; CHILD; CLINICAL TRIAL; CROSS INFECTION; GENETICS; HERPES ZOSTER; INFANT; ISOLATION AND PURIFICATION; NEOPLASM; SKIN TEST; VIROLOGY;

CHICKENPOX; CHICKENPOX VACCINE; CHILD; CLINICAL TRIALS; CROSS INFECTION; DNA, VIRAL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; NEOPLASMS; SKIN TESTS; VACCINES, ATTENUATED;

EID: 0030236952     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70309-3     Document Type: Article

References (67)

1. Y. Asano N. Itakura Y. Hiroishi Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients J Infect Dis 152 1985 863
2. Y. Asano N. Itakura Y. Hiroishi Viremia is present in the incubation period in nonimmunocompromised children with varicella J Pediatr 106 1985 69
3. Y. Asano N. Itakura Y. Kajita Severity of viremia and clinical findings in children with varicella J Infect Dis 161 1990 1095
4. Y. Asano H. Nakayama T. Yazaki Protection against varicella in family contacts by immediate inoculation with live varicella vaccine Pediatrics 59 1977 3
5. Y. Asano H. Nakayama T. Yazaki Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward Pediatrics 59 1977 8
6. Y. Asano K. Shiraki M. Takahashi Soluble skin test antigen of varicella-zoster virus prepared from fluid of infected cultures J Infect Dis 143 1981 684
7. Y. Asano M. Takahashi Clinical and serological testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children Pediatrics 60 1977 810
8. K. Baba K. Shiraki I. Kanesaki Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections J Clin Microbiol 25 1987 2193
9. K. Baba H. Yabuuchi H. Okuni Studies with live varicella vaccine and inactivated skin test antigen: Protective effect of the vaccine and clinical application of the skin test Pediatrics 61 1978 550
10. K. Baba H. Yabuuchi M. Takahashi Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood J Pediatr 100 1982 881
11. K. Baba H. Yabuuchi M. Takahashi Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine J Pediatr 105 1984 714
12. Bogger-Goren K. Baba P. Hurley Antibody responses to varicella-zoster virus after natural or vaccine-infections J Infect Dis 146 1982 260
13. P.A. Brunell C.F. Geiser V. Novelli Varicella-like illness caused by live varicella vaccine in children with acute leukemia Pediatrics 79 1987 922
14. Y. Chiba J. Miura T. Kumagai Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children Biken J 27 1984 67
15. A.J. Davison J.E. Scott The complete DNA sequence of varicella-zoster virus J Gen Virol 67 1986 1759
16. L.D. Gelb D. Dohner Varicella-zoster virus-induced transformation of mammalian cells in vitro J Invest Dermatol 83 1984 77s
17. L.D. Gelb J.J. Huang W.J. Wellinghoff Varicella-zoster virus transformation of hamster embryo cells J Gen Virol 51 1980 171
18. K. Ha K. Baba T. Ikeda Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy Pediatrics 65 1980 346
19. I.B. Hardy A.A. Gershon S.P. Steinberg The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia N Engl J Med 325 1991 1545
20. A. Hattori T. Ihara T. Iwasa Use of live varicella vaccine in children with acute leukemia or other malignancies Lancet 2 1976 210
21. Y. Hayakawa S. Torigoe K. Shiraki Biological and biophysical markers of a varicella vaccine strain (Oka strain): Identification of clinical isolates from vaccine recipients J Infect Dis 149 1984 956
22. Y. Hayakawa T. Yamamoto K. Yamanishi Analysis of varicella zoster virus (VZV) DNAs of clinical isolates by endonuclease Hpal J Gen Virol 67 1986 1817
23. R.E. Hope-Simpson The nature of herpes zoster: A long-term study and a new hypothesis Proc R Soc Med 58 1965 9
24. K. Horiuchi Chickenpox vaccination of healthy children: Immunological and clinical responses and protective effect in 1978-1982 Biken J 27 1984 37
25. T. Izawa T. Ihara A. Hattori Application of a live varicella vaccine in children with acute leukemia or other malignant diseases Pediatrics 60 1977 805
26. H. Kamiya T. Ihara A. Hattori Diagnostic skin test reactions with varicella virus antigen and clinical application of the test J Infect Dis 136 1977 784
27. H. Kamiya R. Kato M. Isaji Immunization of acute leukemic children with a live varicella vaccine (Oka strain) Biken J 27 1984 99
28. H. Kamiya M. Sakurai T. Ihara Clinical use of Oka live varicella vaccine Acta Paediatr Jpn 30 1988 594
29. N. Katsushima N. Yazaki N. Sakamoto Effect and follow-up study on varicella vaccine Biken J 27 1984 51
30. P.R. Kinchington P. Ling M. Pensiero The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka) J Virol 64 1990 4540
31. P.R. Kinchington P. Ling M. Pensiero A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus Adv Exp Med Biol 278 1990 84
32. T. Konno Y. Yamaguchi M. Minegishi A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases Biken J 27 1984 115
33. T. Kumagai Y. Chiba M. Fujiwara Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine Biken J 23 1980 13
34. T. Kurata R. Hondo S. Sato Detection of viral antigens in formalin-fixed specimens by enzyme treatment Ann N Y Acad Sci 420 1983 192
35. P. LaRussa O. Lungo I. Hardy Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates J Virol 66 1992 1016
36. R. Lawrence A.A. Gershon R. Holzman The risk of zoster after varicella vaccination in children with leukemia N Engl J Med 318 1988 543
37. J.H. Martin D.E. Dohner W.J. Wellinghoff Restriction endonuclease analysis of varicella zoster vaccine virus and wild type DNAs J Med Virol 9 1982 69
38. Y. Matsunaga K. Yamanishi M. Takahashi Experimental infection and immune response of guinea pig with varicella zoster virus Infect Immun 37 1982 407
39. 8 + T lymphocytes and epidermal cells in SCID-hu mice J Virol 69 1995 5236
40. Y. Naganuma S. Osawa M. Takahashi Clinical application of live attenuated varicella vaccine (Oka strain) in a hospital Biken J 27 1984 59
41. T. Nunoue Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy Biken J 27 1984 115
42. T. Oka K. Isaki R. Oka Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years Biken J 27 1984 103
43. T. Ozaki T. Ichikawa Y. Asano Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children Biken J 27 1984 29
44. T. Ozaki T. Ichikawa Y. Matsui Lymphocyte-associated viremia in varicella J Med Virol 19 1986 249
45. T. Ozaki T. Ichikawa Y. Matsui Viremic phase in nonimmunocompromised children with varicella J Pediatr 104 1984 85
46. S. Preblud W. Orenstein K. Bart Clinical manifestation, epidemiology, and health impact on children Pediatr Infect Dis J 3 1984 505
47. Y. Sato T. Miyano K. Kawauchi Use of live varicella vaccine in acute leukemia and malignant lymphoma Biken J 27 1984 111
48. K. Shiraki K. Horiuchi Y. Asano Differentiation of Oka varicella vaccine strain from wild varicella-zoster virus isolated from vaccinees and household contact J Med Virol 33 1991 128
49. K. Shiraki M. Takahashi Virus particles and glycoproteins excreted from cultured cells infected with varicella-zoster virus (VZV) J Gen Virol 61 1982 271
50. H. Sugino R. Tsukino Miyashiro Live varicella vaccine: Prevention of nosocomial infection and protection of high risk infants from varicella infection Biken J 27 1984 63
51. M. Takahashi Chickenpox virus Adv Virus Res 29 1983 285
52. M. Takahashi Clinical overview of varicella vaccine: Development and early studies Pediatrics 78 suppl 1986 736
53. M. Takahashi Current status and prospects of live varicella vaccine Vaccine 10 1992 1007
54. M. Takahashi Prospects for a varicella-zoster vaccine A.L. Notkins M.B.A. Oldstone Concepts in Viral Pathogenesis II 1986 Springer-Verlag New York 365
55. M. Takahashi A vaccine to prevent chickenpox R.W. Hyman Natural History of Varicella-Zoster Virus 1987 Florida, CRC Press Boca Raton 179
56. M. Takahashi Y. Asano H. Kamiya Active immunization for varicella-zoster virus A.J. Nahmias W.R. Dowdle R.E. Schinazi Human Herpes Viruses 1981 Elsevier New York 414
57. M. Takahashi K. Baba A live varicella vaccine; its protective effect and immunological aspects of varicella zoster virus infection L. dela Maza E.M. Peterson Medical Virology 1984 Elsevier New York 255
58. M. Takahashi K. Baba K. Horiuchi A live varicella vaccine Adv Exp Med Biol 278 1990 49
59. M. Takahashi A. Gershon Varicella vaccine S.A. Plotkin E.A. Mortimer Jr Vaccines ed 2 1994 WB Saunders Philadelphia 387
60. M. Takahashi Y. Hayakawa K. Shiraki Attenuation and laboratory markers of the Oka-strain varicella-zoster virus Postgrad Med J 61 1985 37
61. M. Takahashi H. Kamiya K. Baba Clinical experience with Oka live varicella vaccine in Japan Postgrad Med J 61 1985 61
62. M. Takahashi T. Otsuka Y. Okuno Live vaccine used to prevent the spread of varicella in children in hospital Lancet 2 1974 1288
63. M. Tsolia A.A. Gershon S.P. Steinberg Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesion in transmission of varicella-zoster virus J Pediatr 116 1990 184
64. C. Tsujino M. Sako M. Takahashi Varicella infection in a children's hospital: Prevention by vaccine and an episode of airborne transmission Biken J 27 1984 129
65. K. Ueda K. Tokugawa F. Nakashima A five year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella Biken J 27 1984 119
66. T.H. Weller H.M. Witton The etiologic agents of varicella and herpes zoster. Serologic studies with the viruses as propagated in vitro J Exp Med 108 1958 869
67. H. Yabuuchi K. Baba N. Tsuda A live varicella vaccine in pediatric community Biken J 27 1984 43